Recombinant Fibrillin 2 (FBN2)
Organism Species:Homo sapiens (Human)
Applications:Positive Control; Immunogen; SDS-PAGE; WB.
.
PROPERTIES
Source |
Prokaryotic expression |
||||||||||||||||||||||||||||||
Host species |
E.coli |
||||||||||||||||||||||||||||||
Residues |
Thr1550~Cys1791 |
||||||||||||||||||||||||||||||
Subcellular Location |
Secreted, Extracellular matrix |
||||||||||||||||||||||||||||||
Tags |
N-terminal His and GST Tag |
||||||||||||||||||||||||||||||
Appearance |
Freeze-dried powder |
||||||||||||||||||||||||||||||
Size |
50 μg |
||||||||||||||||||||||||||||||
Purity |
> 97% |
||||||||||||||||||||||||||||||
Buffer formulation |
20mM Tris, 150mM NaCl, pH8.0, containing 0.01% skl, 5%Trehalose. |
||||||||||||||||||||||||||||||
Predicted isoelectric point |
5.7 |
||||||||||||||||||||||||||||||
Accurate Molecular Mass |
56kDa as determined by SDS-PAGE reducing conditions. |
||||||||||||||||||||||||||||||
Usage |
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex. |
||||||||||||||||||||||||||||||
Storage instructions |
Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months |
||||||||||||||||||||||||||||||
Stability Test |
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition |
||||||||||||||||||||||||||||||
SEQUENCE |
|
NOTE:The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.